ciclopirox has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S | 1 |
| Hassane, DC | 1 |
| Corbett, C | 1 |
| Becker, MW | 1 |
| Jordan, CT | 1 |
| Guzman, ML | 1 |
| Eberhard, Y | 1 |
| McDermott, SP | 1 |
| Wang, X | 1 |
| Gronda, M | 1 |
| Venugopal, A | 1 |
| Wood, TE | 1 |
| Hurren, R | 1 |
| Datti, A | 1 |
| Batey, RA | 1 |
| Wrana, J | 1 |
| Antholine, WE | 1 |
| Dick, JE | 1 |
| Dick, J | 1 |
| Schimmer, AD | 1 |
1 trial available for ciclopirox and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cell Line, Tumor; Ciclopirox; Drug Syner | 2013 |
1 other study available for ciclopirox and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
Topics: Animals; Antifungal Agents; Antimetabolites, Antineoplastic; Apoptosis; Cells, Cultured; Ciclopirox; | 2009 |